Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MammoSite radiation therapy system.

Oscar E Streeter1, Frank A Vicini, Martin Keisch

  • 1Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. ostreeter@mac.com

Breast (Edinburgh, Scotland)
|December 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

ECOG-ACRIN E6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer.

The oncologist·2026
Same author

Patient-Reported Outcomes After Same-Day Mastectomy Among Older Breast Cancer Patients: Results From a Prospective Clinical Trial.

The breast journal·2025
Same author

Case Report: Unique immunotherapy response in a patient with metachronous colorectal cancer not associated with Lynch Syndrome.

Frontiers in oncology·2025
Same author

Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?

Annals of surgical oncology·2025
Same author

ASO Visual Abstract: The Importance of a Pretreatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.

Annals of surgical oncology·2025
Same journal

Antibody-drug conjugates beyond HER2: Translating evidence into practice for HR+ HER2-negative and triple-negative metastatic breast cancer.

Breast (Edinburgh, Scotland)·2026
Same journal

Comment on comparator design in regional versus general anesthesia for ambulatory breast-conserving surgery.

Breast (Edinburgh, Scotland)·2026
Same journal

HER2DX genomic assay in HER2-positive early breast cancer treated with trastuzumab and pertuzumab: A correlative analysis from a real-world cohort.

Breast (Edinburgh, Scotland)·2026
Same journal

Patient satisfaction following Goldilocks mastectomy in non-obese women: A pilot study.

Breast (Edinburgh, Scotland)·2026
Same journal

Concerns about anesthetic standardization and interpretability in the comparison of regional anesthesia with dexmedetomidine versus general anesthesia.

Breast (Edinburgh, Scotland)·2026
Same journal

Translating CLEOPATRA into routine practice: National treatment patterns and survival for patients with HER2-positive metastatic breast cancer.

Breast (Edinburgh, Scotland)·2026
See all related articles

The MammoSite Radiation Therapy System (RTS) is a popular breast cancer treatment due to its simplicity. Long-term complication data is still developing, with new trials underway for DCIS and comparisons to other radiation methods.

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • The MammoSite Radiation Therapy System (RTS) is a widely adopted brachytherapy technique for breast cancer.
  • Its popularity stems from ease of use, a short learning curve, and a single interstitial path requirement.

Purpose of the Study:

  • To review the current status and future directions of the MammoSite RTS in breast cancer treatment.
  • To highlight the need for long-term complication data and ongoing comparative trials.

Main Methods:

  • Review of the MammoSite RTS procedure, including its dosimetry and application.
  • Discussion of developing clinical trials for DCIS and comparative studies with other radiation modalities.

Main Results:

  • MammoSite RTS offers a simplified approach to brachytherapy with straightforward dosimetry.

Related Experiment Videos

  • Limited long-term complication data is currently available, but is an area of active development.

    • Conclusions:

    • MammoSite RTS is a significant advancement in accelerated partial breast irradiation.
    • Further research and long-term data are crucial for fully understanding its efficacy and safety profile.